Lee SD - Search Results

1

Interpersonal Variability in Gut Microbial Calprotectin Metabolism.

Kamp K, Li N, Lachance DM, Saad K, Tolentino E, Yoo L, Heitkemper MM, Clark-Snustad K, Lee SD, Dey N. Kamp K, et al. Among authors: lee sd. Gastro Hep Adv. 2022;1(5):853-856. doi: 10.1016/j.gastha.2022.05.007. Epub 2022 May 20. Gastro Hep Adv. 2022. PMID: 36160305 Free PMC article. No abstract available.

2

Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.

Clark-Snustad KD, Singla A, Lee SD. Clark-Snustad KD, et al. Among authors: lee sd. Dig Dis Sci. 2019 Jul;64(7):1952-1958. doi: 10.1007/s10620-019-05490-0. Epub 2019 Feb 28. Dig Dis Sci. 2019. PMID: 30815825

3

Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.

Jacobs J, Clark-Snustad K, Lee S. Jacobs J, et al. Inflamm Bowel Dis. 2020 Jun 18;26(7):e64. doi: 10.1093/ibd/izaa093. Inflamm Bowel Dis. 2020. PMID: 32342098 Free PMC article. No abstract available.

4

Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.

Lee S, Clark-Snustad K. Lee S, et al. Inflamm Bowel Dis. 2021 Jan 19;27(2):e20-e22. doi: 10.1093/ibd/izaa260. Inflamm Bowel Dis. 2021. PMID: 33119736 No abstract available.

5

Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.

Lee SD, Singla A, Harper J, Barahimi M, Jacobs J, Kamp KJ, Clark-Snustad KD. Lee SD, et al. Inflamm Bowel Dis. 2022 Feb 1;28(2):309-313. doi: 10.1093/ibd/izab176. Inflamm Bowel Dis. 2022. PMID: 34347103 Free PMC article.

6

Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis.

Barahimi M, Lee S, Clark-Snustad K. Barahimi M, et al. Case Rep Gastroenterol. 2021 Jul 20;15(2):662-666. doi: 10.1159/000514952. eCollection 2021 May-Aug. Case Rep Gastroenterol. 2021. PMID: 34720824 Free PMC article.

7

Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease.

Kamp KJ, Clark-Snustad K, Barahimi M, Lee S. Kamp KJ, et al. Gastroenterol Nurs. 2022 Jan-Feb 01;45(1):21-28. doi: 10.1097/SGA.0000000000000600. Gastroenterol Nurs. 2022. PMID: 35020629 Free PMC article.

8

Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.

Lee SD, Singla A, Harper J, Barahimi M, Jacobs J, Kamp KJ, Clark-Snustad KD. Lee SD, et al. Dig Dis Sci. 2022 Aug;67(8):4043-4048. doi: 10.1007/s10620-022-07444-5. Epub 2022 Mar 14. Dig Dis Sci. 2022. PMID: 35288831 Free PMC article.

9

Deep Remission in Severe Refractory Crohn's Disease With Mycophenolate Mofetil.

Jacobs J, Clark-Snustad K, Lee S. Jacobs J, et al. Inflamm Bowel Dis. 2023 Feb 1;29(2):332-333. doi: 10.1093/ibd/izac213. Inflamm Bowel Dis. 2023. PMID: 36223271 No abstract available.

10

Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease.

Lee SD, Kamp K, Clark-Snustad KD. Lee SD, et al. Crohns Colitis 360. 2022 Apr 27;4(2):otac012. doi: 10.1093/crocol/otac012. eCollection 2022 Apr. Crohns Colitis 360. 2022. PMID: 36777048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,497 results

Search Page

Filters